kedarcidin chromophore: a 9-membered enediyne, isolated from an actinomycete strain; embedded in kedarcidin peptide; extremely active against P388 leukemia & B16 melanoma; structure given in first source
ID Source | ID |
---|---|
PubMed CID | 6444256 |
MeSH ID | M0215182 |
Synonym |
---|
kedarcidin chromophore |
143591-04-2 |
2-naphthalenecarboxamide, n-(13-chloro-2,3,6,7-tetradehydro-10-((2,6-dideoxy-3-c-methyl-alpha-l-ribo-hexopyranosyl)oxy)-1a,9-dihydro-20-oxo-23-((2,4,6-trideoxy-4-(dimethylamino)-alpha-l-lyxo-hexopyranosyl)oxy)-9,5-(epoxy(5,2)pyridinopropanoxyethano)-10h-c |
n-[(3s,9r,14s,15e,19s,21r,24r)-6-chloro-24-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-14-[(2s,4s,5s,6s)-5-(dimethylamino)-4-hydroxy-6-methyloxan-2-yl]oxy-11-oxo-4,12,20-trioxa-7-azapentacyclo[13.6.2.25,8.13,21.019,21]hexacosa-1,5,7,15,25-penta |
Kedarcidin chromophore is a 9-membered enediyne, recently isolated from an actinomycete strain.
Excerpt | Reference | Relevance |
---|---|---|
"Kedarcidin chromophore is a 9-membered enediyne, recently isolated from an actinomycete strain. " | ( Kedarcidin chromophore: an enediyne that cleaves DNA in a sequence-specific manner. Casazza, AM; Colson, KL; Doyle, TW; Leet, JE; Schroeder, DR; Solomon, W; Zein, N, 1993) | 3.17 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (42.11) | 18.2507 |
2000's | 9 (47.37) | 29.6817 |
2010's | 2 (10.53) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.32) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 19 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |